SCB-219M

· Sichuan Clover Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCB-219M, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) [Phase 1]